[Immunocharacteristics of bone marrow mesenchymal stem cell]

Area of Science:

• Immunology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) possess immunomodulatory properties.
• Understanding MSC immunocharacteristics is crucial for therapeutic applications.

Purpose of the Study:

• To investigate the immunocharacteristics of bone marrow MSCs.
• To evaluate the therapeutic potential of MSCs, particularly their role in immune regulation and post-transplantation behavior.

Main Methods:

• Rat bone marrow MSCs were isolated and characterized.
• MSC immunophenotype, growth dynamics, and cell cycle were analyzed.
• MSCs were treated with interferon gamma (IFNg) and analyzed for immune marker expression (PDL-1, CD54, CD40, CD80, CD86, MHC-I, MHC-II) via flow cytometry.
• The role of PDL-1 and CD54 in MSC-mediated inhibition of mixed lymphocyte reaction (MLR) was assessed using blocking antibodies.
• Cytokine levels (IFN, IL-2, IL-4, IL-10) in MLR supernatant were quantified by ELISA.
• MSC homing to the liver and microchimerism induction were analyzed post-transplantation.

Main Results:

• High purity MSCs exhibited specific growth phases and cell cycle distribution.
• IFNg treatment upregulated CD54, PDL-1, MHC-I, and MHC-II expression on MSCs, while CD40, CD80, and CD86 remained unexpressed.
• MSCs inhibited MLR, with IFNg enhancing this effect.
• Blocking PDL-1 or CD54 partially reversed MSC-mediated MLR inhibition.
• MLR supernatant showed high IFN-gamma and IL-10, low IL-4, and undetectable IL-2.
• Transplanted MSCs demonstrated liver homing and induced microchimerism.

Conclusions:

• Interferon gamma (IFNg) enhances the immunomodulatory capacity of MSCs by upregulating PD-L1 and CD54.
• PD-L1 and CD54 are critical mediators of MSC-induced inhibition in mixed lymphocyte reactions.
• MSCs possess the ability to home to the liver and establish microchimerism following transplantation, indicating potential for therapeutic use.